Arbutus Biopharma Aktie
3,91
EUR
+0,01
EUR
+0,26
%
4,72
USD
+0,29
USD
+6,43
%
Werbung
Arbutus Biopharma Aktie Analyse
| 16.10.18 | Arbutus Biopharma Buy | B. Riley FBR | |
| 12.10.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 19.03.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 05.01.18 | Arbutus Biopharma Buy | B. Riley FBR, Inc. | |
| 04.04.17 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 01.02.17 | Arbutus Biopharma Outperform | Wedbush Morgan Securities Inc. | |
| 30.11.16 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 06.11.15 | Arbutus Biopharma Outperform | RBC Capital Markets | |
|
Werbung
|
|||
Werbung
Werbung